Literature DB >> 946007

Editorial: The inexcusable disease.

G Edsall.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 946007     DOI: 10.1001/jama.235.1.62

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Immunizations in the elderly.

Authors:  D W Bentley
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

2.  Tetanus in adults: results of the multicenter ID-IRI study.

Authors:  S Tosun; A Batirel; A I Oluk; F Aksoy; E Puca; F Bénézit; S Ural; S Nayman-Alpat; T Yamazhan; V Koksaldi-Motor; R Tekin; E Parlak; P Tattevin; K Kart-Yasar; R Guner; A Bastug; M Meric-Koc; S Oncu; A Sagmak-Tartar; A Denk; F Pehlivanoglu; G Sengoz; S M Sørensen; G Celebi; L Baštáková; H Gedik; S Dirgen-Caylak; A Esmaoglu; S Erol; Y Cag; E Karagoz; A Inan; H Erdem
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-28       Impact factor: 3.267

3.  Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study.

Authors:  Muriel Stubbe; Luc J M Mortelmans; Didier Desruelles; Rohnny Swinnen; Marc Vranckx; Edmond Brasseur; Philippe E Lheureux
Journal:  Emerg Med J       Date:  2007-09       Impact factor: 2.740

4.  Therapeutic efficacy of human anti-tetanic globulin--a clinical study of 100 cases.

Authors:  M M Bagree; J D Singh; D L Kanwar; R C Nagar
Journal:  Jpn J Surg       Date:  1982

5.  [Tetanus immunity in an urban population: gaps in the vaccination of senior citizens and foreign guest workers].

Authors:  G T Werner; W E Berdel; N Frühwein
Journal:  Soz Praventivmed       Date:  1985

Review 6.  Cost-effectiveness of primary tetanus vaccination among elderly Canadians.

Authors:  B G Hutchison; G L Stoddart
Journal:  CMAJ       Date:  1988-12-15       Impact factor: 8.262

Review 7.  Global distribution of infectious diseases requiring intensive care.

Authors:  Raul E Istúriz; Jaime Torres; José Besso
Journal:  Crit Care Clin       Date:  2006-07       Impact factor: 3.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.